Elsevier Launches Exam Consult - an Online Exam Preparation Tool for UK Medical School ExamsBy Elsevier, PRNE
Wednesday, May 4, 2011
LONDON, May 5, 2011 - Elsevier, the world-leading publisher of scientific, technical
and medical information products and services, announces the launch of Exam
Consult, an online exam preparation and simulation tool. The first of several
online question banks planned for 2011, the initial release offers
preparation for the challenging medical finals exams.
Exam Consult offers students the opportunity to prepare with
questions closely matched to their curriculum, written by expert contributors
and assessed by a panel of experts (
www.examconsult.co.uk/examconsult/contributors.cfm). John Rees, Head
of Medical Education and Dean of Undergraduate Education at King's College
London School of Medicine has been heavily involved with the creation of Exam
Consult and offers the following assurance, "As an external examiner for two
UK Medical Schools, I know the types of questions asked and Exam Consult
really offers realistic finals practice, with a mix of single-best answer
questions and extended-matching questions for all disciplines."
Further, Exam Consult allows students to identify their areas
of weakness by system, discipline, competence and in comparison to peers.
This detailed analysis of results is uniquely available with Exam Consult and
allows students to tailor their preparation, therefore maximizing efficiency.
Students can further address their weak areas with targeted learning provided
by trusted Elsevier brands, including Kumar & Clark's Clinical Medicine,
Davidson's Principles and Practice of Medicine and the Crash Course series.
Feedback from students demonstrates Exam Consult is well
received by students, "Easy to use and fully comprehensive - excellent
preparation for Finals exams," 5th year medical student, Newcastle
A free 7-day trial of Exam Consult is available at
www.examconsult.co.uk. Full subscriptions are available for 3 months,
6 months or 12 months. For subscriptions or further information, please visit
Elsevier is a world-leading publisher of scientific, technical
and medical information products and services. The company works in
partnership with the global science and health communities to publish more
than 2,000 journals, including The Lancet (www.thelancet.com/) and
Cell (www.cell.com/), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com/), SciVerse Scopus
(www.scopus.com/home.url), Reaxys (https://www.reaxys.com/info/), MD
Consult (www.mdconsult.com/php/240581084-199/homepage) and Nursing
Consult (www.nursingconsult.com/php/240586898-10/home.html), which
enhance the productivity of science and health professionals, and the SciVal
suite (www.scival.com/) and MEDai's Pinpoint Review (
www.medai.com/), which help research and health care institutions
deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier
(www.elsevier.com/wps/find/homepage.cws_home) employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC (
www.reedelsevier.com/Pages/Home.aspx), a world-leading publisher and
information provider, which is jointly owned by Reed Elsevier PLC and Reed
Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London
Stock Exchange), RUK and ENL (New York Stock Exchange).
Media Contact Tom Reller VP, Corporate Relations, Elsevier T.Reller@elsevier.com +1-215-239-3508
Tags: Elsevier, London, May 5, United Kingdom